Matulane and Miralax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Matulane (procarbazine hydrochloride) and Miralax (polyethylene glycol 3350). Common drug interactions include fatigue among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Matulane and Miralax. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Matulane?

Matulane has active ingredients of procarbazine hydrochloride. eHealthMe is studying from 3,440 Matulane users. Check the latest studies of Matulane.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

On Jul, 18, 2026

44 people who take Matulane and Miralax together, and have interactions are studied.

What are the common drug interactions of Matulane and Miralax, by gender? *:

female:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Urticaria (rash of round, red welts on the skin that itch intensely)
Vomiting
Alopecia (absence of hair from areas of the body)
Body temperature increased
Contusion (a type of hematoma of tissue in which capillaries)
Diarrhoea
Gastric disorder (disease of stomach)

male:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Abdominal pain upper
Adverse event
Arthralgia (joint pain)
Back pain
Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Nail discolouration (change in nail colour)

What are the common drug interactions of Matulane and Miralax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Platelet count decreased
White blood cell count decreased

10-19:

Vomiting
Alopecia (absence of hair from areas of the body)
Hypoaesthesia (reduced sense of touch or sensation)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Vision blurred
Back pain
Decreased appetite
Dyspepsia (indigestion)
Nausea (feeling of having an urge to vomit)
Weight decreased

20-29:

n/a

30-39:

n/a

40-49:

Rash generalised (rash on most of body parts)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

50-59:

Neuropathy peripheral (surface nerve damage)
Urticaria (rash of round, red welts on the skin that itch intensely)
Adverse event
Diarrhoea
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)

60+:

Fatigue (feeling of tiredness)
Decreased appetite
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Platelet disorder
Red blood cell count decreased

What are the existing conditions these people have? *

Brain Neoplasm Malignant (brain cancer tumour): 19 people, 43.18%
Hodgkin's Lymphoma (cancer originating from white blood cells): 8 people, 18.18%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 9.09%
Brain Neoplasm Benign (non-cancerous tumour of brain): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Matulane and Miralax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously